Related Experiment Video
Updated: Jul 1, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
A data-driven approach to choosing privacy parameters for clinical trial data sharing under differential privacy.
Henian Chen1, Jinyong Pang1, Yayi Zhao1
1Study Design and Data Analysis, College of Public Health, University of South Florida, Tampa, FL 33612, United States.
Differential privacy (DP) can anonymize clinical trial data for secure sharing. This study identified optimal privacy budget (ε) values, showing DP closely approximates original data metrics at specific ε thresholds, enhancing data utility and privacy.
Area of Science:
- Medical research
- Data privacy
- Statistical analysis
Background:
- Clinical trial data sharing is vital for research transparency and collaboration.
- Differential privacy (DP) is a state-of-the-art anonymization technique balancing data privacy and accuracy using a privacy budget (ε).
- DP is currently underutilized in clinical trial data sharing.
Purpose of the Study:
- To identify appropriate privacy budget (ε) values for sharing clinical trial data using differential privacy.
- To evaluate the accuracy of DP-protected data compared to original clinical trial datasets.
Main Methods:
- Analyzed two clinical trial datasets using DP with privacy budgets (ε) from 0.01 to 10.
- Compared key statistical metrics (rates, odds ratios, means) between original and DP-estimated data.
- Investigated the impact of increasing ε on data accuracy and privacy.
Main Results:
- DP-estimated rates closely matched original rates (6.5%) when ε > 1.
- DP-estimated odds ratios aligned with original ratios (0.689) when ε ≥ 3.
- DP-estimated means approximated original means (164.64) when ε ≥ 1, with convergence observed as ε increased to 5.
Conclusions:
- Differential privacy demonstrates significant promise for secure and accurate clinical trial data sharing.
- The study provides insights into selecting privacy budget (ε) values for DP application in clinical research.
- Further research is needed to establish consensus on choosing ε for optimal privacy-utility balance.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Blinding
Mechanistic Models: Compartment Models in Individual and Population Analysis
Censoring Survival Data
Data Collection by Experiments
An example of the experimental method is a public...
Randomized Experiments
Simple randomization
Simple...

